DemeRx is a subsidiary of atai that aims to develop ibogaine for Opioid Use Disorder.


“DemeRx is a clinical stage pharmaceutical development company advancing two lead drug candidates as medication-assisted therapies for opioid addiction. Our natural prod­uct lead drug – lbogaine – is an indole alkaloid from equatorial Africa, which blocks opioid withdrawal symptoms and drug cravings, helping drug dependent patients to transition to sobriety. The Company has developed a robust IP portfolio around Noribogaine, the principal active metabolite of lbogaine.”

Company Information

DemeRx Website

January, 2020


Explore more company info with a Tree membership

📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates

Explore memberships


HQ / Office 1951 Northwest 7th Avenue suite 600, Miami, FL, USA